Recently Funded Series D Biotechnology Startups
Updated Sep 2026
FundedIQ tracks 79 funded Series D Biotechnology startups, with their funding rounds, amounts, investors, industries, locations and company details. This page provides an overview of the Series D Biotechnology startup funding landscape, along with the 79 most recently funded Series D Biotechnology startups.
New York and Cambridge hold the deepest concentrations of these companies. Series D Biotechnology startups closed 27 funding rounds over the last 24 months, 19 of them in the last 12 months, and raised $2.7B in disclosed capital. The median disclosed round is $78M, with the middle half of rounds falling between $52M and $119M.
These companies possess mature operational structures and significant headcounts. Their presence in New York and Cambridge reflects a shift toward established corporate scale. This stage represents a transition from experimental research to commercial readiness. Such organizations act as enterprise buyers with substantial budgets and complex procurement processes.
Series D Biotechnology funded startup statistics
Most recent funding round on record: Aug 2026.
79 most recently funded Series D Biotechnology startups
79 shownOrdered by the date of the latest funding round. Each row gives the company, its location and industry, what it does, the stage and date of that round, and the disclosed amount.
Series D Biotechnology startup funding trends
Funding activity
Series D Biotechnology startups closed 27 funding rounds over the last 24 months, 19 of them in the last 12, adding up to $2.7B in disclosed capital.
Round sizes
The median disclosed round is $78M, with the middle half running from $52M to $119M. 24 of 27 rounds disclosed an amount.
Company size
The most common headcount band across the segment is 11-50.
Countries with the most funded Series D Biotechnology startups
Where funded Series D Biotechnology startups are headquartered, by the country on the company record.
Where are funded Series D Biotechnology startups located?
Where funded Series D Biotechnology startups are based, by the city on the company record.
About the FundedIQ Series D Biotechnology startup funding data
FundedIQ tracks announced startup funding rounds and organises them by company, funding date, stage, amount, industry, location and investor. The dataset is refreshed weekly, and new rounds are normalised and de-duplicated before they are published, so the same round reported twice on different dates is recorded once.
Figures on this page cover the 79 funded Series D Biotechnology startups currently tracked. Round counts, capital totals and the median round are computed over a trailing 24 months. Rounds whose amount was not disclosed (3 of 27 in that period) are counted as rounds but excluded from capital totals and from the median. The most recent round on record for funded Series D Biotechnology startups is dated Aug 2026.
The table above shows the 79 most recently funded companies. Full funding histories, investor lists and founder contacts across the whole dataset open on a FundedIQ plan.
Frequently asked questions
How many funded Series D Biotechnology startups are there?
FundedIQ tracks 79 funded Series D Biotechnology startups. This page lists the 79 most recently funded of them, ordered by the date of their latest round, and the full set is available on a FundedIQ plan.
How much funding have Series D Biotechnology startups raised?
Series D Biotechnology startups tracked by FundedIQ have raised $2.7B in disclosed capital across 27 funding rounds over the last 24 months, including 19 rounds in the last 12 months. 24 of those 27 rounds disclosed an amount; undisclosed rounds are excluded from the capital total.
Which countries have the most funded Series D Biotechnology startups?
United States leads with 59 companies, ahead of Germany (3), Belgium (2) and Canada (2).
Which cities have the most funded Series D Biotechnology startups?
New York leads with 7 companies, then Cambridge (5), San Diego (4) and San Francisco (4).
What is a typical funding round size for Series D Biotechnology startups?
The median disclosed round over the last 24 months is $78M, and the middle half of rounds fall between $52M and $119M. Round sizes vary widely by stage, so the seed and later-stage bands sit well either side of that figure.
How often is the Series D Biotechnology startup funding data updated?
The dataset is refreshed weekly. New rounds are normalised and de-duplicated before they are published, and the most recent round currently on record for funded Series D Biotechnology startups is dated Aug 2026. Counts and totals on this page are recomputed on every refresh.
Related listings
Know who just raised. Then know who to reach.
Every newly funded startup with its round, its investors and its founders: delivered weekly by email, or searchable in the app.
Alerts from $19/mo · Pro from $99/mo. Card required, nothing charged until day 15, and we email you 3 days before that.